10/28/2025 | Short News
Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has again been named to the Top 100 Women-Led Businesses in Massachusetts. The annual list is compiled by The Women’s Edge in partnership with The Boston Globe Maga ## Article Body 10/28/2025 | Short News Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has again been named to the Top 100 Women-Led Businesses in Massachusetts. The annual list is compiled by The Women’s Edge in partnership with The Boston Globe Magazine. Fresenius Medical Care ranked #4 – as it did in 2024. Helen Giza, CEO and Chair of the Management Board, continues to lead the company’s strategic realignment under the FME Reignite strategy, which will guide Fresenius Medical Care’s direction and innovation in kidney care for the coming years. In 2024, Fresenius Medical Care received FDA clearance for the 5008X™ CAREsystem, enabling hemodiafiltration (HDF) therapy in the United States for the first time. The company continues the rollout of the 5008X in the U.S. for the commercial rollout in 2026. This advancement introduces our patients in the U.S. to a new treatment that has demonstrated promising results in Europe and other regions, including reduced hospitalization rates and lower mortality rates. FME has achieved a global Patient Net Promoter Score of 72, reflecting strong patient trust and satisfaction across care settings. The company is uniquely positioned in the industry as the only dialysis provider with a successful vertically integrated structure that combines services and medtech. The Women’s Edge is a Boston-based nonprofit organization that supports women leaders across industries. This year marks the 25th anniversary of its Top 100 list, which recognizes organizations making a measurable impact on the Massachusetts economy through leadership, innovation, and performance. Rankings are based on revenue, diversity, and other key metrics. The ranked list was revealed at the Women’s Edge awards breakfast on Friday, October 24, and published in the October 26 edition of the Boston Globe’s Women & Power magazine. The full list can be viewed here. Back To top: ## Recent Company News - 2026-07-29 07:00 EST — [Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients](https://biopharmsignal.com/news/FMS/fresenius-medical-care-announces-beacon-us-generating-real-world-evidence-suppor-8547f5f8) — Source: Fresenius Medical Care Ventures - 2026-07-20 07:00 EST — [Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy](https://biopharmsignal.com/news/FMS/fresenius-medical-care-introduces-therapywise-analytics-for-kidney-replacement-t-6fa82f2a) — Source: Fresenius Medical Care Ventures - 2026-06-10 07:00 EST — [Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model](https://biopharmsignal.com/news/FMS/interwell-health-delivers-strong-quality-scores-and-shared-savings-in-cms-value--e2c55e86) — Source: Fresenius Medical Care Ventures - 2026-06-03 07:00 EST — [Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-kinexus-worldwide-a-unified-digital-platform-to-support-home-dialysis) — Source: Fresenius Medical Care Ventures - 2026-05-28 07:00 EST — [Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million](https://biopharmsignal.com/news/FMS/fresenius-medical-care-launches-first-tranche-of-its-share-buyback-program-of-up-to-eur-600-million) — Source: Fresenius Medical Care Ventures ## Related News - 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627) - 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922) - 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c) - 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec) - 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)